Navigation Links
Unigene's Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
Date:12/12/2012

BOONTON, N.J., Dec. 12, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that the results of its successful Phase 2 clinical trial evaluating an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women has been published online by Bone, the Official Journal of the International Bone and Mineral Society. The article will be published in the paper version of the journal in the coming months.

This peer reviewed manuscript, entitled, "Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant Human Parathyroid Hormone [rhPTH(1-31)NH2] in Postmenopausal Women with Osteoporosis," provides the full efficacy and safety data from Unigene's Phase 2 clinical study of oral PTH in the treatment of osteoporosis in 97 postmenopausal women.  Kim Henriksen, MSc, PhD, Head of Musculoskeletal Diseases at Nordic Bioscience served as the lead author of the article, which was jointly prepared by authors from Nordic Bioscience, Unigene Laboratories, the Center for Clinical and Basic Research (CCBR) and GlaxoSmithKline (GSK).

Ashleigh Palmer, Unigene's Chief Executive Officer, stated, "We are extremely pleased that a peer-reviewed article detailing the positive Phase 2 results from our oral PTH program was published in such a prestigious scientific journal as Bone.  The data and analysis once again demonstrate the strength of Unigene's proprietary oral peptide drug delivery technology and the clinical potential and commercial viability of our oral PTH analog.  I would like to extend my congratulations to Dr. Henriksen for leading the publication effort and to the entire team of contributors from Nordic Bioscience, CCBR, GSK and Unigene for their tremendous wor
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
2. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
3. uniQure Initiates Phase I in Acute Intermittent Porphyria
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
6. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
7. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
8. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
9. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... medical technology company, today scheduled a conference call to ... fiscal year 2013, ended April 30, 2013. The call ... 30, 2013. The Company will report financial results for ... markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... May 23, 2013  TeamHealth Medical Call Center ... and nurse advice lines, announces its newly formed ... nursing and administrative leaders, provides clinical expertise to ... cost-effective services for hospital clients, physician clients and ... system evolves, it,s imperative to continuously advance our ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... this week,s 46th Annual Midyear Clinical Meeting and Exhibition ... Health launched BarCode360™ , a solution that supports ... timely and cost efficient to order medications and ensure ... bedside. ASHP has set a goal for ...
... The Ministry of Health and Welfare and The Korean ... Dhabi and four Korean hospitals, including Samsung Seoul Hospital, ... St. Mary,s Hospital have signed an agreement to collaborate ... Nov. 25. This agreement represents the first ...
Cached Medicine Technology:Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 2Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 3South Korea Signs Accord with Abu Dhabi Health Authority on Hospital Service Agreement 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 Imagine running the ... the energy loss, hot air and wasted energy! If the ... fan, a fireplace or clothes dryer, that may be just ... from these often overlooked holes waste energy in the form ... heating and cooling loss in the home. , Drafts occur ...
(Date:5/25/2013)... It's not astonishing that holidays are amongst the most ... from family, friends and co-workers. Between the parties to ... their parents can afford, parties to arrange, and so ... anniversaries and it seems like an eternal cycle of ... and income can’t catch up to the expenses of ...
(Date:5/25/2013)... May 25, 2013 An experienced Chandler ... in partnership with JD Media Surge, LLC. , ... now available and, depending on the treatment, can be ... routine visit, the best method will be chosen for ... during a visit. A special peroxide-based whitening gel is ...
(Date:5/25/2013)... Communities of Distinction TV announces May ... largest media market in the United States with almost three ... in Texas and a major convention city. Ft. Worth is ... it is home to many major museums. Both cities offer ... the arts. Residents and locals will be able to watch ...
(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... federal multidistrict litigation underway in U.S. District Court, Western ... LLP reports. According to a Case Management Order ... that govern the filing of contested motions in the ... filing those motions. (In re: Actos Product Liability Litigation, ...
Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3
... By Julia VanTine HealthDay Reporter , THURSDAY, ... took two or more epilepsy drugs while pregnant fared worse ... medications, a large Swedish study has found. Also, ... lower in several subjects, including math and English. ...
... HOUSTON ― A $16-million, five-year grant by the National ... research institutions to focus an array of innovative nanotechnologies ... pancreatic cancers. The Texas Center for Cancer Nanomedicine, ... grant assembles researchers from The University of Texas MD ...
... , , , , , , , ... , , , ... Although more research is needed, the researchers... , Click here for more information. ... , , , , , , ...
... brain science meeting, will be held Nov. 13-17 in San ... mental illness, genetics, aging, diet, behavior, and related disorders. ... disorders will be presented in press conferences at Neuroscience 2010, ... largest source of emerging news on brain science and health. ...
... Dotinga HealthDay Reporter , THURSDAY, Nov. 4 (HealthDay ... Americans are sicker than their counterparts in the United Kingdom ... Brits, thanks to doctors and drugs. "Americans are taking ... health-care system," explained study co-author James P. Smith, a senior ...
... at the ends of our chromosomes, known as telomeres. In ... our telomeres get shorter. This is part of the natural ... not have much active telomerase. Eventually, these DNA-containing telomeres, which ... so short that the cells die. But ...
Cached Medicine News:Health News:Teens of Epileptic Mothers May Lag Academically: Study 2Health News:Teens of Epileptic Mothers May Lag Academically: Study 3Health News:Texas Center for Cancer Nanomedicine targets 2 tough cancers 2Health News:Texas Center for Cancer Nanomedicine targets 2 tough cancers 3Health News:Texas Center for Cancer Nanomedicine targets 2 tough cancers 4Health News:Gene identified for spread of deadly melanoma 2Health News:Gene identified for spread of deadly melanoma 3Health News:Gene identified for spread of deadly melanoma 4Health News:Gene identified for spread of deadly melanoma 5Health News:Gene identified for spread of deadly melanoma 6Health News:Live streaming of emerging brain science and health news 2Health News:Older Americans Sicker Than British Peers... 2Health News:New 3-D model of RNA 'core domain' of enzyme telomerase may offer clues to cancer, aging 2Health News:New 3-D model of RNA 'core domain' of enzyme telomerase may offer clues to cancer, aging 3Health News:New 3-D model of RNA 'core domain' of enzyme telomerase may offer clues to cancer, aging 4Health News:New 3-D model of RNA 'core domain' of enzyme telomerase may offer clues to cancer, aging 5
... Monitoring Lumen., ,Designed for neonatal and ... incorporates a monitoring lumen within the wall ... distal tip. Luer lock connector bonded to ... monitoring, pressure monitoring or syringe irrigation of ...
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Nasal soft cuffed endotracheal tubes designed and constructed especially for long-term nasal intubations....
Pediatric Tracheal Tubes with Micro-thin-walled cuffs....
Medicine Products: